Method for predicting patient response to immunotherapy
AssigneeThe Board of Trustees of the Leland Stanford Junior University
InventorsChristian M. SCHÜRCH, Darci J. Phillips, Garry P. Nolan
Life of this patent
Estimating the term…
Loading patent…
AssigneeThe Board of Trustees of the Leland Stanford Junior University
InventorsChristian M. SCHÜRCH, Darci J. Phillips, Garry P. Nolan
Estimating the term…
Provided herein, among other things, is a method for predicting how a patient responds to immunotherapy. In some embodiments, the method may comprise: performing a multiplexed binding assay on a tissue section of a tumor obtained from a cancer patient to identify at least cancer cells, effector immune cells and immunosuppressive cells in the tissue section; measuring, for each cell of a plurality of the effector immune cells: (i) the physical distance to its most proximal cancer cell; and (ii) the physical distances to its most proximal immunosuppressive cell; and calculating, for each of the effector immune cells analyzed, the ratio of the distance measured in step (i) and distance measured in step (ii), wherein the ratio is predictive of the patient's response to immunotherapy. The method may be used to select patients for immunotherapy.
A method for predicting response to immunotherapy, comprising:
A method of treatment comprising:
A method for selecting a patient for treatment by an immune checkpoint inhibitor, comprising:
Dependencies are inferred from the claim text.